IC
PRQR icon

Ikarian Capital’s ProQR Therapeutics PRQR Stock Holding History

Ikarian Capital’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Hold
1,492,229
– – 0.35% 91
2025
Q4 		$3.01M Buy
1,492,229
+600,000
+67% +$1.4M 0.39% 86
2025
Q3 		$1.9M Buy
892,229
+24,160
+3% +$52.8K 0.38% 103
2025
Q2 		$1.77M Buy
+868,069
New +$1.41M 0.59% 70
2024
Q4 		– Sell
-483,583
Closed -$880K – 216
2024
Q3 		$880K Hold
483,583
– – 0.27% 102
2024
Q2 		$803K Hold
483,583
– – 0.25% 82
2024
Q1 		$1.1M Buy
483,583
+10,958
+2% +$23.4K 0.3% 101
2023
Q4 		$936K Hold
472,625
– – 0.26% 102
2023
Q3 		$614K Hold
472,625
– – 0.23% 107
2023
Q2 		$766K Hold
472,625
– – 0.27% 89
2023
Q1 		$1.01M Buy
472,625
+50,000
+12% +$153K 0.42% 79
2022
Q4 		$1.56M Buy
+422,625
New +$554K 0.65% 45

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return